Abstract
BackgroundLow-density lipoprotein cholesterol (LDL) lowering via inhibition of PCSK9 is an important cornerstone in treatment of hypercholesterolemia. There is currently no data regarding safety of PCSK9 inhibitor therapies in pregnancy....
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have